Discrimination against an individual prohibited for the refusal of medical interventions for reasons of conscience, including religious conviction.
HF481 would create a new Minnesota law protecting individuals who refuse certain medical interventions for reasons of conscience, including religious convictions. The bill defines covered medical interventions broadly to include biologic vaccines, pharmaceuticals, drugs, gene-editing technology, RNA-based products, and DNA-based products. It applies to a wide range of entities, including employers, businesses, health care providers, hospitals, health plans, nursing homes, political subdivisions, public officials, private colleges, state agencies, and state institutions of higher education.
The bill prohibits those entities from denying employment, services, access to commerce, or public services; segregating; penalizing; using financial coercion; or otherwise treating a person differently because of refusal of a covered intervention. It also creates enforcement rights for affected individuals, allowing them to seek injunctive relief or declaratory judgment and to file private civil actions for money damages. Prevailing plaintiffs would be entitled to court costs, reasonable attorney fees, and, in damages actions, treble damages or at least $200, whichever is greater. The bill states that its protections prevail over conflicting general law unless a specific exemption exists, while also clarifying that it does not bar recommendation, education, or access to the covered interventions.
If enacted, HF481 would add a new chapter to Minnesota Statutes and impose anti-discrimination obligations on a broad range of public and private actors with respect to individuals who decline certain medical interventions on conscience or religious grounds. It would create a private right of action and fee-shifting/damages remedies, which could significantly affect employment practices, health care operations, educational institutions, and public services. The bill would also potentially limit the application of conflicting state laws to the extent they do not contain specific exemptions.
Based on the bill text and the absence of committee testimony or recorded votes, the available record shows the bill was introduced by House members and referred to the Committee on Commerce Finance and Policy, but no formal legislative sentiment can be measured from hearings or roll calls. The caption and structure suggest the bill is intended to protect conscience-based refusals, especially in the context of vaccines and other medical interventions, which typically draws support from religious liberty and medical freedom advocates. At the same time, the breadth of the bill indicates it could raise concerns among health care, employer, and public-sector stakeholders about compliance and liability.
The main points of contention are likely to be the scope of the protected refusals and the breadth of the entities covered. Opponents may object that the bill reaches beyond vaccines to include pharmaceuticals, gene-editing technology, RNA-based products, and DNA-based products, and that it applies to employers, health plans, hospitals, nursing homes, schools, and government bodies. Another likely dispute is the enforcement mechanism: the bill authorizes private lawsuits, attorney fees, and enhanced damages, which could be viewed as creating substantial litigation risk. Supporters would likely emphasize conscience protections, religious freedom, and non-discrimination for individuals who decline medical interventions.